Children and adolescents with obesity-associated high blood pressure

Journal of the American Society of Hypertension

Volumn 2, Issue 4, 2008, Pages 267-274

  Falkner, Bonita ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

cardiovascular; Hypertension; insulin resistance; metabolic risk factors

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CARDIOVASCULAR DISEASE; CHILD; CHILD HEALTH CARE; DISEASE ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

EID: 47049095493     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.01.003     Document Type: Review

References (84)

1. Still J.L., and Cottom D. Severe hypertension in childhood. Arch Dis Child 42 (1967) 34-39
2. Pickering T.G., Hall J.E., Appel L.J., Falkner B., Graves J., Hill M.N., et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111 (2005) 697-716
3. National High Blood Pressure Education Program Working Group on high blood pressure in children and adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 114 (2004) 555-576
4. Hansen M.L., Gunn P.W., and Kaelber D.C. Underdiagnosis of hypertension in children and adolescents. JAMA 298 (2007) 874-879
5. McNiece K.L., Poffenbarger T.S., Turner J.L., Fanco K.D., Sorof J.M., and Portman R.J. Prevalence of hypertension and prehypertension among adolescents. J Pediatr 150 (2007) 640-644
6. Ogden C.L., Flegel K.M., Carroll M.D., and Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288 (2002) 1728-1732
7. Munter P., He J., Cutler J.A., Wildman R.P., and Whelton P.K. Trends in blood pressure among children and adolescents. JAMA 291 (2004) 2107-2113
8. Falkner B., Gidding S.S., Ramirez-Garnica G., Wiltrout S.A., West D., and Rappaport E.B. The relationship of body mass index with blood pressure in primary care pediatric patients. J Pediatr 148 (2006) 195-200
9. Cook N.R., Gillman M.W., Rosner B.A., Taylor J.O., and Hennekens C.H. Prediction of young adult blood pressure from childhood blood pressure, height, and weight. J Clin Epidemiol 50 (1997) 571-579
10. Lauer R.M., Mahoney L.T., and Clarke W.R. Tracking of blood pressure during childhood: the Muscatine Study. Clin Exp Hypertens 8 (1986) 515-537
11. Falkner B., Hulman S., and Kushner H. Birth weight vs childhood growth as determinants of adult blood pressure. Hypertension 32 (1998) 145-150
12. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
13. Thomas F., Bean K., Pannier B., Opert J.-M., Guize L., and Benetos A. Cardiovascular mortality in overweight subjects. The key role of associated risk factors. Hypertension 46 (2005) 654-659
14. Burns T.L., Moll P.P., and Lauer R.M. Increased familial cardiovascular mortality in obese schoolchildren: the Muscatine Ponderosity Family Study. Pediatrics 89 (1992) 262-268
15. Fox E., Taylor H., Andrew M., Han H., Mohamed E., Garrison R., et al. Body mass index and blood pressure influences on left ventricular mass and geometry in African-Americans. The Atherosclerotic Risk in Communities (ARIC) Study. Hypertension 44 (2004) 55-60
16. Drukteinis J.S., Roman M.J., Fabsitz R.R., Lee E.T., Best L.G., Russel M., et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults. The Strong Heart Study. Circulation 115 (2007) 221-227
17. Sorof J.M., Turner J., Martin D.S., Garcia K., Garami Z., Alexandrov A.V., et al. Cardiovascular risk factors and sequelae in hypertensive children identified by referral versus school-based screening. Hypertension 43 (2004) 214-218
18. Lande M.B., Carson N.L., Roy J., and Meagher C.C. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension 48 (2006) 1-5
19. Pausova Z., Gaudet D., Gossard F., Bernard M., Kaldunski M.L., Jomphe M., et al. Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension 46 (2005) 1280-1285
20. Reaven G. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
21. Meigs J.B. Invited commentary: insulin resistance syndrome?. Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152 (2000) 908-911
22. Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
23. Falkner B., Onesti G., Angelakos E.T., Fernandez M., and Langman C. Cardiovascular response to mental stress in normal adolescents with hypertensive parents. Hypertension 1 (1979) 23-30
24. Rocchini A.P., Key J., Bondie D., Chico R., Moorehead C., Katch V., et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321 (1989) 580-585
25. Harshfield G.A., Wilson M.E., McLeod K., Hanevold C., Papuku G.K., Mackey L., et al. Adiposity is related to gender differences in impaired stress-induced pressure natriuresis. Hypertension 42 (2003) 1082-1086
26. Wilson M.E., Harshfield G.A., Ortiz L., Hanevold C., Kapuka G., Mackey L., et al. Relationship of body composition to stress-induced pressure natriuresis in youth. Am J Hypertens 17 (2004) 1023-1028
27. Julius S. Cocoran lecture: sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21 (1993) 886-893
28. Sun S.S., Grave G.D., Siervogel R.M., Pickoff A.A., Arslanian S.S., and Daniels S.R. Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 119 (2007) 237-246
29. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr 83 (2006) 1237-1247
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2487
31. Alberti K.G., and Zimmer P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications, I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 15 (1998) 539-553
32. Cook S., Weitzman M., Auinger P., Nguyen M., and Dietz W. Prevalence of a metabolic syndrome phenotype in adolescents. Arch Pediatr Adolesc Med 157 (2003) 821-827
33. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
34. Sorof J., and Daniels S. Obesity hypertension in children. A problem of epidemic proportions. Hypertension 40 (2002) 441-447
35. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal. Diabetes Care 28 (2005) 2289-2304
36. Bao W., Srinivasan S.R., Wattigney W.A., and Berenson G.S. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med 154 (1994) 1842-1847
37. Katzmarzyk P.T., Perusse L., Malina R.M., Bergeron J., Despres J.P., and Bouchard C. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Quebec Family Study. J Clin Epidemiol 54 (2001) 190-195
38. Raitakari O.T., Juonala M., Kahonen M., Taittonen L., Laitinen T., Maki-Torkko N., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290 (2003) 2277-2283
39. Daniels S.R., Loggie J.M.H., Khoury P., and Kimball T.R. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97 (1998) 1907-1911
40. Hanevold C., Waller J., Daniels S., Portman R., and Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 113 (2004) 328-333
41. Rocchini A.P., Moorehead C., Katch V., Key J., and Finta K.M. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension 19 (1992) 615-620
42. Oren A., Vos L.E., Uiterwaal C.S.P.M., Gorissen W.H.M., Grobbee D.E., and Bots M.L. Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: the Atherosclerosis Risk in Young Adults Study. Int J Obes 27 (2003) 1383-1390
43. Li S., Chen W., Srinivasan S.R., Bond M.G., Tang R., Urbina E.M., et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood. The Bogalusa Heart Study. JAMA 290 (2003) 2271-2276
44. Sorof J.M., Alexandrov A.V., Garami Z., Turner J.L., Grafe R.E., Lai D., et al. Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 18 (2003) 1020-1024
45. Berenson G.S., Wattigney W.A., Tracy R.E., Newman W.P., Srinivasan S.R., Webber L.S., et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol 70 (1992) 851-858
46. McGill Jr. H.C., McMahan C.A., Malcom G.T., Oalmann M.C., and Strong J.P. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 15 (1995) 431-440
47. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
48. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
49. McLaughlin T., Abbasi F., Lamendola C., Liang L., Reaven G., Schaaf P., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106 (2002) 2908-2912
50. Moon Y.S., Kim D.H., and Song D.K. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metab Clin Exper 53 (2004) 863-867
51. Warnberg J., Nova E., Moreno Lam Romeo J., Mesana M.I., Ruiz J.R., Ortega F.B., et al. and the AVENA Study Group. Inflammatory proteins are related to total and abdominal adiposity in healthy adolescent population: the AVENA Study. Am J Clin Nutr 84 (2006) 505-512
52. Yoshida T., Kaneshi T., Shimabukuro T., Sunagawa M., and Ohta T. Serum C-reactive protein and its relation to cardiovascular risk factors and adipocytokines in Japanese children. J Clin Endocrinol Metab 91 (2006) 2133-2137
53. Lambert M., Devlin E.E., Paradis G., O'Loughlin J., Hanley J.A., and Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 50 (2004) 1762-1768
54. Vikram N.K., Misra A., Dwivedi M., Sharma R., Pandey R.M., Luthra K., et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 168 (2003) 305-313
55. Kelly A., Wetzsteon R.J., Kaiser D.R., Steinberger J., Bank A.J., and Dengel D.R. Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. J Pediatr 145 (2004) 731-736
56. Sinaiko A.R., Steinberger J., Moran A., Prineas R.J., Vessby B., Basu S., et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 111 (2005) 1985-1991
57. Kelly A.S., Steinberger J., Kaiser D.R., Olson T.P., Bank A.J., and Dengel D.R. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr 1 (2006) 248-253
58. de Ferranti S.D., Gauvereau K., Ludwig D.S., Newburger J.W., and Rifai N. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem 52 (2006) 1325-1330
59. Ford E.S. C-reactive protein concentration and cardiovascular disease risk factors in children. Findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 108 (2003) 1053-1058
60. Pittas A.G., Joseph N.A., and Greenberg A.S. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89 (2004) 447-452
61. Pickup J.C., Chusney G.D., Thomas S.M., and Burt D. Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 67 (2000) 291-300
62. Haffner S.M., Mykkanen L., Rainwater D.L., Karhapaa P., and Laakso M. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?. Obes Res 7 (1999) 164-169
63. Festa A., D'Agostino Jr. R., Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51 (2002) 1131-1137
64. Winkler G., Salamon F., Salamon D., Speer G., Simon K., and Cseh K. Elevated serum tumor necrosis factor-alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 41 (1998) 860-861
65. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
66. Arita Y., Kihara S., Ouchi N., Maeda K., Miyagawa J., Hotta K., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
67. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamota Y., et al. Adipocyte-derived plasma protein, adiponectin, suppress lipid accumulation and class A receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
68. Okamoto Y., Arita Y., Nishida M., Maraguchi M., Ouchi N., Takahashi M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32 (2000) 47-50
69. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
70. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
71. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103 (2002) 137-142
72. Weiss R., Dufour S., Groszmann A., Petersen K., Dziura J., Taksali S.E., et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 88 (2003) 2014-2018
73. Asayama K., Hayashibe H., Dobashi K., Uchida N., Nakane T., Kodera K., et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 11 (2003) 1072-1079
74. Stefan N., Bunt J.C., Salbe A.D., Funahashi T., Matsuzawa Y., and Tataranni P.A. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 87 (2002) 4652-4656
75. Bottner A., Kratzsch J., Muller G., Kapellen T.M., Bluher S., Keller E., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89 (2004) 4053-4061
76. Degawa-Yamauchi M., Dilts J.R., Bovenkerk J.E., Saha C., Pratt J.H., and Considine R.V. Lower serum adiponectin levels in African-American boys. Obes Res 11 (2003) 1384-1390
77. Shimabukuro M., Higa N., Asahi T., Oshiro Y., Takasu N., Tagawa T., et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88 (2003) 3236-3240
78. Fernandez-Real J.-M., Castro A., Vazquez G., Casamitjana R., Lopez-Bermejo A., Penarroja G., et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 27 (2004) 739-745
79. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., and Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16 (2003) 72-75
80. Kazumi T., Kawaguchi A., Sakai K., Hirano T., and Gen Y. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25 (2002) 971-976
81. Daniels S.R., Lipman M.J., Burke M.J., and Loggie J.M. The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension. Am J Ophthalmol 111 (1991) 205-208
82. Mitchell P., Cheung N., de Haseth K., Taylor B., Rochtchina E., Amirul Islam F.M., et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension 49 (2007) 1156-1162
83. Baker J.L., Olsen L.W., and Sorensen T.I.A. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357 (2007) 2329-2337
84. Bibbins-Domingo K., Coxson P., Pletcher M.J., Lightwood J., and Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med 357 (2007) 2371-2379